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A prospective comparison of dynamic contrast-
enhanced MRI and 51Cr-EDTA clearance for 




To evaluate the performance of dynamic contrast-enhanced MRI measurement of 
glomerular filtration rate (GFR) compared with the reference standard technique of 
urinary clearance of 51Cr-EDTA. 
Patients and methods: 
All kidney transplant recipients (KTRs) with an indication for non-urgent contrast-
enhanced MRI at our institution were prospectively included between 2008 and 2012. 
Renographies were acquired by low-dose DCE-MRI then fitted with a two-compartment 
pharmacokinetic model. MR-GFR was compared with reference isotopic measurements 
using Bland-Altman diagrams, intraclass correlation coefficient (ICC) and concordance 
rates. 
Results: 
Forty-two KTRs (mean age 51.5 years, 26 – 74) were analyzed. Mean estimated GFR 
was 48.5±27mL/min/1.73m2 (24–178 mL/min). The mean bias was +13.2 mL/min (6.4–
20.0, +36.9%) ranging from -31.0 mL/min (-41.7%) to +101.4 mL/min (+89.2%) with a 
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large variability (standard-deviation: 22.3 mL/min; limits of agreement: [-30.6 (-43.3–-
18.9); +57.0 (45.3–68.7)]). The ICC was 0.32 (0.02–0.56) and the concordance rate was 
28.6% (14.9–42.2). 
Conclusions: 
The large variability of MR-GFR compared with the reference technique precludes its 
use in KTRs, whose anatomical peculiarities make standardization of arterial input 
function (AIF) difficult.  
 










































































AIF: arterial input function 
DCE-MRI: dynamic contrast-enhanced MRI 
Gd-CM: gadolinium based contrast media 
GFR: glomerular filtration rate 





































































GFR is the hallmark of kidney function in clinical practice. It is generally estimated using 
formulas that reflect the balance between endogenous synthesis and renal elimination of 
biological markers (namely creatinine and/or cystatin C) (1). These formulas were built 
by regression in large specific-population samples. As such, their use to estimate a 
specific individual’s kidney function is often problematic. Measuring the clearance of 
exogenous markers infused into a patient’s bloodstream is considered to be the gold 
standard for GFR measurement. However, these techniques are not well suited for 
routine evaluation of kidney function because they are either costly and cumbersome or 
rely on hypotheses that cannot always be justified. In addition, most often they require 
nuclear medicine services.  
Gadolinium-based contrast media (Gd-CM) have an excellent renal safety profile even in 
patients with impaired kidney function (2), and have the same pharmacokinetics as the 
tracers used for clearance measurement techniques (3). Dynamic contrast-enhanced 
MRI (DCE-MRI) monitors the distribution of Gd-CM in anatomic structures. In 
association with mathematical models that describe this process, these imaging 
techniques are promising tools to evaluate kidney function and other physiological 
parameters of potential interest in nephrology (e.g. renal blood flow, and vascular or 
tubular transit times). Compared with isotopic methods, MRI provides high-quality 
anatomic descriptions of the studied organs and as such, it could provide functional 
maps of native and transplanted kidneys.  
Many studies have found encouraging results for native kidneys, in both healthy or 



































































protocol and the model used, and error variability was excessively large. Actually, only 
Lim (11) achieved performances compatible with a clinical use of the technique.  
To our knowledge, the case of KTRs has been studied only by Yamamoto et al. (12). 
These authors focused on the diagnostic value of tubular transit times for acute 
rejection, but did not compare MR-GFR with a reference measurement. Investigation of 
KTRs offers a rewarding clinical study group because technically they show only slight 
respiratory movements, and clinically their follow-up often implies iterative graft biopsies, 
making non-invasive procedures highly worthwhile. Moreover, most of them present an 
impaired kidney function, and filtration is almost completely performed by the kidney 
allograft so that there is no need to determine differential filtration to compare MR-GFR 
with reference GFR estimations. This is the first study whose aim was to compare the 
performances of DCE-MRI GFR measurements with 51Cr-EDTA clearance as a 
reference technique in KTRs.  
2. Materials and methods  
2.1. Patients  
This prospective study was approved by the institutional review board and the 
interregional ethics authorities (Comité de protection des personnes Sud-Ouest et 
Outre-Mer III), and informed written consent was obtained from all patients. Between 
January 2008 and January 2012, all patients with renal transplantation followed in our 
department, whose medical condition required a non-urgent contrast-enhanced MRI of 



































































MDRD formula (13), were considered for inclusion to undergo a low-dose MR 
renography.  
Patients with contraindications to MR examinations or isotopic determinations of the 
GFR were not included in the study (pregnant or breast-feeding women, patients with 
implanted electronic devices, metallic foreign bodies or surgical clips, severe 
claustrophobia, known intolerance or allergy to Gd-CM).  
Demographic data was gathered from the patients’ medical records and from electronic 
databases. A blood sample was taken to measure creatininemia and hematocrit. 
Isotopic GFR measurement and DCE-MRI examination were performed on the same 
day to avoid any change in kidney function between measurements. 
2.2. Magnetic resonance imaging 
MRI images were acquired on a 1.5T MRI scanner (ACS-NT - Philips) using a body 
phased-array coil. A three-dimensional saturation-recovery turbo-field echo sequence 
was used with the following parameters: TE /TR = 3.7/6.2ms; θ = 10◦; slice thickness = 
10mm, no gap; 5 slices; acquisition matrix 60×240; reconstructed matrix 256×256; 
approximate voxel size: 1.6×1.6×10mm3; parallel imaging (SENSE method, 1.7 
reduction factor). The saturation pulse was applied non-selectively to avoid inflow effects 
within the volume. A coronal oblique section was selected to include both the entire 
kidney allograft on its long axis and the terminal abdominal aorta within the acquisition 
volume, and centered on the renal pedicle. However, in difficult cases, kidney 
parenchyma was given priority over the terminal aorta, provided that an arterial signal 



































































The temporal resolution of the sequence was approximately 2 seconds. Before and after 
injection of the contrast agent, images were acquired iteratively 200 times across 6 min 
40 s without breath holds; the patient was simply asked to breath slowly. As of the 20th 
acquisition, each patient received an intravenous injection of 0.07 mL/kg (33% of a 
standard dose) of gadoterate-meglubine (Dotarem©; Guerbet, Roissy, France) with an 
infusion rate of 2 mL/s, followed by a 20 mL saline flush at 2 mL/s. 
In addition to the functional sequence, all subjects underwent standard T1-weighted 
gradient echo and T2-weighted fast spin-echo imaging, and 3D contrast-enhanced MR 
angiography for morphologic assessment. 
2.2.1. Data analysis  
Image processing  
Area under the Gd-CM concentration curve (AUC) was computed for each voxel of the 
functional acquisition. For each patient, a threshold was manually chosen to identify a 
small subset of voxels with the highest AUC in the aorta or the common iliac artery. This 
lead to select a region in the center of the terminal aorta, 2-3 pixels away from aortic 
boundaries. Quite often, the anatomical configuration made it impossible to acquire both 
the graft and the terminal aorta in the same data volume. In such cases, the arterial 
region of interest (ROI) was selected in the common iliac artery or in the upper aorta, 
depending on the place where the highest AUC were found. The AUC image was also 
used to manually delineate the kidney parenchyma (pelvis excluded) on each of the five 
slices available for each patient. Motion of the kidney during the acquisition was ignored. 



































































The arterial and renal signals were averaged over the corresponding ROI before being 
used as input for the model-fitting algorithm. Signals corresponding to the images and 
segmentations given on Fig. 1 are presented as examples on Fig. 2. Kidney volume ( ) 
was computed directly from these ROI as the product of a voxel volume by the number 
of voxels in the selected region.  
Image manipulations and delineations were performed offline using a program 
developed by (initials) using PMI (v. 0.4) and written in IDL (v 6.3). 
Compartment model  
The distribution of Gd-CM in the kidney was described using the compartmental model 
proposed by Sourbron et al. (9) and depicted on Fig. 3. 
Gadolinium concentration was assumed to be proportional to the increase of the signal 
intensity from the basal situation, denoted   , which was computed from the 20 first 
images:                   . Coefficient   is unknown but cancels out in further 
computations so that it does not need estimating. The plasma concentration of 
gadolinium in the aorta was computed from full blood concentration by correcting for the 
hematocrit when available. For eleven patients it was not known and was replaced with 
the mean value over the whole cohort (35.5%).  
The 4 parameters of the model (renal plasma flow,    , plasma volume relative to the 
kidney volume, tubular mean transit time) were determined by fitting the predicted tissue 
concentration with measured data (likelihood maximization using the Levenberg-
Marquardt algorithm (14)). The convergence of the optimization algorithm to a plausible 



































































Computations were implemented in Python and its associated scientific computing 
libraries (15). 
2.2.2. Isotopic GFR measurement 
Reference GFR values were obtained by measurements of 51Cr-EDTA renal clearance 
(16). A bolus of 100 μCi (3.7 MBq) 51Cr-EDTA was injected at t=0. Each patient was 
asked to drink 5 mL/kg of water at the beginning of the examination and 90mL at t=60 
min and asked to void at t=60 min. Blood samples were taken at  =75, 105, 135 and 165 
min to determine the plasma concentrations of 51Cr-EDTA (  ). Patients were asked to 
void at t=90, 120, 150 and 180 min and to drink 90mL water at each of these time point. 
The volume of urine and urine concentrations of 51Cr-EDTA were determined for each of 
these samples (      ,       ). 
 
The GFR was determined as the mean of four calculations of the urinary clearance of 
51Cr- EDTA for each time point:  




             
   
 
               
    
 
                 
    
 
                 
    
  
An expert (initials) reviewed all these measurements. Patients showing significant 
deviations from this protocol or with large discrepancies between the four clearance 
measurements (coefficient of variation over 10%) were excluded from the study.  
2.2.3. Statistics  
MR-GFR and 51Cr-EDTA-GFR were compared using Bland-Altman diagrams (17–19), 
intra-class correlation coefficients (ICC) (20) and concordance rates (namely, the 



































































between the two techniques). Linear regression and correlation coefficients were given 
for comparison with previous works. Normality of error distribution in the Bland-Altman 
analysis was tested using Kolmogorov-Smirnov tests. 
As we expected an ICC greater than 0.8, we calculated the minimum sample size to be 
55 to obtain a lower bound of the 95% confidence interval of at least 0.6 (this threshold 
is considered to represent good agreement between the investigated techniques) (21). 
Demographic data are presented as mean ± standard−deviation or median [first; third 
quartile] when appropriate. Comparisons of GFR measurement error between 
subgroups were performed using Wilcoxon tests. Subgroups were defined depending on 
the immunosuppressive regimen, the indication of MRI examinations, and the 
abnormalities reported by the radiologist who interpreted the standard morphological 
acquisitions. 
Statistics were computed using the R software (version 3.1.2) and the corresponding 
packages (22,23).  
3. Results   
Patient selection is shown in the flow diagram in Fig. 4. Sixty-nine patients were initially 
included in the study. Twenty-seven were excluded because MR renography was not 
interpretable (MRI artefacts or poor positioning of the acquisition volume resulting in 
sequences without dependable arterial signal) (15 patients), or because their isotopic-
GFR calculation was untrustworthy (12 patients). Finally, 42 patients were analysed (29 



































































from kidney transplantation to isotopic measurements and MRI examination was 
397 [113; 1145] days. 
For most patients, acquiring both the entire kidney and the terminal abdominal aorta at 
the same time proved impossible and arterial ROI had to be selected in the upper aorta 
or in the common iliac artery: the ROI was taken in the aorta for 35/42 (83.3%) patients, 
and in the iliac artery for 7/42 (16.7%) patients. The size of the arterial ROI was on 
average 62±28 voxels (median: 54.5, range: 23—154) for the aortic region, and 
8878±2318 voxels (median: 8089.5, range: 5617—15262) for the kidney parenchyma 
(average volume of the kidney: 203±50 mL; median: 192; range: 135—321). 
Mean estimated GFR (MDRD formula) of our patients was 48.5±27 mL/min/1.73m2 
(eGFR range: from 24 to 178). Mean GFR measured by the isotopic reference technique 
was 41.8±14.5 mL/min (EDTA-GFR range: from 18.3 to 81.1). Mean GFR measured by 
DCE-MRI was 55.0±26.0 mL/min (MR-GFR range: from 23.9 to 170.1 mL/min). As 
plasma samples were available, we also determined the plasma clearance of 51Cr-EDTA 
according to Bröchner-Mortensen’s technique (24) as an alternative reference 
measurement. As already stated in previous works (25), the two techniques were in 
good agreement, plasma clearance being slightly higher that renal clearance (mean 
difference between measurements: 4.3±7.6 mL/min). The use of either reference 
technique did not change the conclusion of our study (see supplemental material Fig. S3 
and S4). 
The comparison between MR-GFR and the reference method is depicted in Fig. 5. 



































































regression line of MR-GFR against EDTA-GFR had a slope of 0.92 and an intercept 
of 16.5 mL/min. Our measurement protocol lead to a large overestimation of the GFR 
compared with the reference technique. The mean difference with the reference 
technique was +13.2±22.3 mL/min (6.4—20.0, +36.9%) with a large variability (limits of 
agreement: [-30.6(-42.3—-18.9); 57.0(45.3—68.7)]). The ICC was 0.32 (0.02—0.56), far 
below the 0.6 threshold for satisfactory agreement between the two techniques. The 
concordance rate was 28.6% (14.9—42.2). Finally, on average, the systematic bias was 
slightly increasing with the GFR value (+0.28 mL/min per mL/min increase). 
When comparing subgroups of patients depending on their immunosuppressive 
regimen, the indication for the MRI, or the morphological abnormalities, no specific 
characteristic presented a significant association with larger measurement errors 
(Fig. 6). 
To investigate the influence of ROI selection on measured GFR, we restricted our 
analysis to the patients for whom the AIF could be determined from the aorta (36/42, 
86% of patients). In these patients, the mean bias was 11.6±18.3 mL/min, with 
[-24.2(-34.6—-13.8); +47.6(37—57.8)] limits of agreement (vs.13.2±22.3 mL/min in the 
whole cohort). The decrease in error variability was not statistically significant (p=0.38 
for the modified one-sided paired Pitman-Morgan test). In a second experiment the AIF 
was determined from the iliac artery in a region as close as possible of the implantation 
of the kidney allograft artery and the GFR was computed using this new AIF (this was 
possible for 37/42 (88%) patients). In comparison with the aortic AIF, the mean bias was 
24.2±25.5 mL/min (vs. 11.6±18.3) with [-25.8(-40.3—-11.3); +74.3(59.8—88.8)] limits of 



































































(p=0.26). The associated Bland-Altman diagrams are presented in the supplemental 
material (Fig. S2). 
4. Discussion   
This is the first study performed in a cohort of KTRs for whom non-invasive GFR 
measurement would be extremely worthwhile and who show a wide range of GFR 
values measured with a reference technique. We chose to exclude all the patients with 
doubtful isotopic measurements (12/69) to reinforce the value of this reference 
technique, keeping only trustworthy results.  
Overall, while using DCE-MRI to estimate GFR was feasible for KTRs, compared to the 
reference technique, DCE-MRI strongly overestimated GFR and exhibited a large 
variability with poor intra-class correlation coefficients and low concordance rates.  
Whereas there is no other experience in the literature on KTRs for comparison, our 
results are somewhat consistent with previously published work on native kidneys but 
exhibit a higher systematic bias and larger error variability. 
Using a Rutland-Patlak technique in 28 diseased subjects, Hackstein et al. (5) found a 
correlation coefficient r=0.86 between iopromide clearance measurements and MR-
GFR, and a standard deviation from the regression line of 14.8 mL/min. In 39 patients 
with a large range of GFR, Buckley et al. (6) also found a strong correlation between 
isotopic reference measurements and MR-GFR (Spearman’s  : 0.81). In another 
population of diseased subjects, using and slightly different pharmacokinetic models but 



































































results: mean bias of -11.8 and -18.1 mL/min, and variability of ±13.7 and ±13.9 mL/min 
respectively in comparison with isotopic GFR determination (correlation coefficient was 
r=0.82). In the same population, with the same acquisition protocol and reference 
technique but with 8 different pharmacokinetic models, Bokacheva et al. (9) also found a 
good correlation between MR-GFR and reference measurements (correlation 
coefficients ranging from 0.74 to 0.85). Nonetheless, biases were highly dependent on 
the model used, ranging from -52% to -2.5%. Vivier et al. (11) experimented other 
acquisition and post-treatment protocols with variants of the pharmacokinetic model by 
Zhang et al. in 20 patients with cirrhosis. Depending on the variant of the model and the 
orientation of the slice used for the post-processing, they found a median bias ranging 
from -7.7 to -4.1 mL/min, with a root mean square error between 12.8 and 12.9 mL/min. 
The most promising results were obtained by Lim et al. in diseased patients with a wide 
range of GFR (12). Compared with reference isotopic GFR measurements, their protocol 
achieved a non-significant mean bias of -0.7 mL/min and variability of ±5.86 mL/min, 
small enough to be compatible with clinical use. 
Discrepancies of our results with previous works could be explained both by anatomic 
characteristics of transplanted kidneys compared to natives ones and by our workflow 
with respect to these characteristics.  
In term of anatomic characteristics, in contrast with native kidneys, renal allografts 
exhibit a large variability in their anatomical configurations. This problem, which has 
been highly underestimated, made very difficult to combine an accurate positioning of 
the acquisition slab along the long axis of the graft and inclusion of the terminal aorta or 



































































standardized and reproducible ROIs selection for the AIF. The 10mm thick coronal slices 
also favoured partial volume effects (PVE), mainly when AIF had to be sampled on iliac 
arteries instead of aorta, resulting in an underestimation of the AIF, and subsequently, in 
an overestimation of GFR. As the importance of PVE depends on the position of the 
acquisition matrix with respect to the arteries, which cannot be controlled, this probably 
accounts for a large part of the higher variability we noticed compared with 
measurements on native kidneys. The increase in the bias noticed when using an AIF 
sampled from the iliac arteries (see supplemental material, Fig. 4), which are more 
prone to PVE due to their smaller diameter, is consistent with this hypothesis. Finally, 
the close proximity of renal parenchyma with iliac vessels could also produce PVE, 
mixing signals coming from both structures.  
Considering the model of Gd-CM pharmacokinetics, the interstitial compartment induces 
large overestimation of GFR. This hypothesis is consistent with the results obtained in 
most previous studies since the most negative biases are noticed mostly in the patients 
with the highest reference GFR measurements. In our cohort, most patients had an 
impaired kidney function, a setting often associated with fibrosis in KTRs, which could 
explain the observed positive bias. However, no histological evaluation of the interstitial 
volume was performed, and this hypothesis remains speculative.  
Also, in our population of KTRs, the whole filtration function was attributed the 
transplant. However, some patients actually have a residual function from their native 
kidneys that presumably ranges from 0 to 10 mL/min. While this hypothesis is not 
consistent with GFR overestimation, it cannot be ruled out and may explain part of the 



































































At last, kidney motion was ignored because transplants are located far away from the 
diaphragm muscle. However spontaneous voluntary or digestive motions actually 
occurred and have inescapably increased error variability. This suggests that, even for 
KTRs, motion correction could prove beneficial to obtain reproducible results. 
5. Conclusion  
This first study on the performance of MR-measurement of GFR in KTRs with respect to 
a reference technique shows that, even if kidney grafts are unique, less mobile and 
more superficially located, an overestimation and a large variability still precludes its use 
in clinical practice without significant improvements. Anatomical constraints make the 
standardization of ROI selection more difficult than in native kidneys and lead to larger 
and unpredictable partial volume effects. These characteristics hamper an accurate and 
reproducible measurement of AIF and probably contribute for a large part to bias and 
variability.  
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Tab. 1. Demographic characteristics of the 42 kidney-transplant recipients 
and 34 donors analyzed. The number of patients for which the data were available is 




































































Fig. 1. Examples of manual delineations of arterial and parenchymal region of 
interest (red regions) on the AUC images. Left: case where both the terminal aorta 
and the kidney allograft could be included in the same acquisition volume. Isotopic GFR 
was 34.4 mL/min, MR-GFR was 60.7 mL/min. Right: case where the anatomical 
configuration made this impossible. In this case, the distinction between the common 
iliac aorta and the allograft parenchyma is very difficult, due to anatomical proximity and 
partial volume effects (white arrows). Isotopic GFR was 81.1 mL/min, MR-GFR was 69.4 
mL/min.  
 
Fig. 2. Gadolinium concentration time curves in the blood (red, solid), the allograft 
parenchyma (black, dashed), and predicted by the model with the optimal 
parameters (purple, dash-dotted). The presented signals correspond to the mean 
value of the corresponding ROIs, as presented on Fig. 1. Left (top), and Fig. 1. Right 
(bottom). 
 
Fig. 3. Pharmacokinetic model used in the study. Gadolinium enters the vascular 
compartment (denoted  , with a volume   ) with arterial plasma with a flow that 
corresponds to the renal plasmatic flow (   ) and a concentration      . Part of it is 
filtered into a tubular compartment (denoted e, with a volume   ) with a coefficient that 
corresponds to the glomerular filtration rate (   ). The remaining (       ) is 
returned to the general circulation. The filtered gadolinium is subsequently eliminated 
into the bladder with a transit time that is a parameter of the model. The dashed line 
represents reabsorption of gadolinium-free fluid. 
 
Fig. 4. Flow-chart of the study. Twelve patients were excluded because their 
reference measurement was not reliable (large discrepancies between the four 
measurements of the renal clearance of 51Cr-EDTA). Fifteen patients were excluded 
because the MRI acquisition was not suitable for GFR measurements (MRI artifacts, bad 
positioning of the acquisition volume). 
 
Fig. 5. Relationship between MR-GFR and the reference measurements. Top-left: 
linear regression of MR-GRF against 51Cr-EDTA clearance: slope was 0.92, intercept 
was 16.5 mL/min, correlation coefficient was 0.52. The regression line is plotted with a 
solid line. The (ideal) identity line is plotted with a dashed line. Each point corresponds 
to one the measurements for one patient. Top-right: Bland-Altman diagram. The dashed 
line represents the mean bias over the whole cohort (+13.2 mL/min). Dotted lines 
represent the limits of agreement ([-30.6; +57.0]). Normality of errors was tested using a 
Kolmogorov-Smirnov test (      ). The ideal no-difference line is draw with a solid 
line. Each point corresponds to the measurement for one patient. Bottom-left: Bland-
Altman analysis with log-transformed data (Kolmogorov-Smirnov test:       ). Bottom-
right: limit of agreement computed from Bland-Altman analysis of the log-transformed 
data. On average, the systematic bias is slightly increasing with the GFR (+0.28 mL/min 
per mL/min increase). The dashed line corresponds to the mean ratio between the bias 
and the mean of EDTA clearance and MR-GFR. The dotted lines correspond to the limit 




































































Fig. 6. Discrepancies between EDTA clearance and MR-GFR (relative values) 
depending on the use of calcineurin inhibitors in the patient’s immunosuppressive 
regimen (Wilcoxon exact test:       ), the indication of the MRI examinations (exact 
Wilcoxon tests:       ,     ,     ,     ,      for hypertension, vascular anomaly, 
urological anomaly, renal mass and kidney failure respectively), and on the 
abnormalities reported by the radiologist (Wilcoxon exact test:       ,     ,      and 
     for the association with renal artery stenosis, dilation of pelvi-caliceal cavities, 
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Characteristics Value   
Patient   
 age (yrs) 51.5±12.9 42 
 males / females 29 (69.1%) / 13(30.9%)  42 
 eGFR (mL/min/1.73m2)* 48.5±27.0 42 
 hematocrit (%) 35.5±5.3 31 
Kidney donor   
 age (yrs) 50.6±16.6 34 
 males 17 (50%) 34 
 females 17 (50%) 34 
Elapsed time from graft to MRI 397 [113; 1445] 42 
Immunosuppressive regimen   
 calcineurin inhibitors 37 (88.1%) 42 
Indication for MRI examination 
 vascular anomaly 24 (57.2%) 42 
 urologic anomaly 8 (19%) 42 
 arterial hypertension 3 (7.1%) 42 
 kidney failure 2 (4.8%) 42 
 renal mass 2 (4.8%) 42 
 other 3 (7.1%) 42 
*eGFR according to the MDRD formula 
 
 
Tab. 1. Demographic characteristics of the 42 kidney-transplant recipients 
and 34 donors analyzed. The number of patients for which the data were available is 
given in the third column ( ). 
Table 1
Figure 1
















































































































42 patients with both a valid
51Cr-EDTA clearance
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